Gut microbes

Mediterranean diet-based supplement may reduce harmful brain protein buildup and inflammation by changing gut bacteria in Alzheimer's mice

Updated

Abstract

Essence

In , a Mediterranean diet-inspired supplement was linked to lower hippocampal amyloid deposits and microglial activation alongside microbiome and metabolite changes.

Evidence

This 12-week randomized preclinical mouse study used male and female 5xFAD mice with multi-omics profiling and brain staining to assess microbiota, metabolites, amyloid-beta deposition, and Iba-1-positive microglia.

Caveat

The findings are preclinical and association-based within a transgenic mouse model, so the microbiota-gut-brain mechanism and therapeutic potential in human AD remain unproven.

Simplified

Key numbers

4.33
Reduction in Amyloid Deposits
F(1,27) = 4.33; p=0.048 for percentage area of amyloid deposits
8.55
Decrease in Microglia
F(1,27) = 8.55; p=0.007 for Iba-1 positive microglia count
13.14
Increased Serotonin Levels
F(1,27) = 13.14; p=0.001 for serotonin concentration

Full Text

What this is

  • Alzheimer's disease (AD) prevalence is rising, necessitating effective interventions.
  • This study examines a Mediterranean diet-inspired supplement, Neurosyn240, for its effects on AD pathology in .
  • The research focuses on how Neurosyn240 impacts the , potentially influencing amyloid deposition and microglial activation.

Essence

  • Neurosyn240 significantly reduced hippocampal amyloid deposits and microglial activation in . These effects are linked to changes in gut microbiota and increased serotonin levels.

Key takeaways

  • Neurosyn240 altered gut microbiota composition, leading to increased serotonin levels and decreased levels of certain bile acids. These metabolic changes may contribute to neuroprotective effects.
  • Consumption of Neurosyn240 resulted in a significant reduction in the percentage area of amyloid deposits in the hippocampus, suggesting potential benefits in mitigating AD pathology.
  • The number of Iba-1 positive microglia in the hippocampus was significantly reduced with Neurosyn240 intake, indicating a decrease in neuroinflammation associated with amyloid pathology.

Caveats

  • The study's findings are based on a specific mouse model and may not fully translate to humans. Further research is needed to confirm the efficacy of Neurosyn240 in clinical settings.
  • The analysis was limited to three biological replicates per group and sex, which may restrict the statistical power and generalizability of the results.
  • The 5xFAD model does not capture tau-related pathology, which is characteristic of later stages of AD, limiting the study's scope regarding comprehensive AD pathology.

Definitions

  • microbiota-gut-brain axis: The bidirectional communication network linking gut microbiota to brain function, influencing neuroinflammation and cognitive health.
  • 5xFAD mice: A transgenic mouse model that exhibits early-onset Alzheimer's disease pathology, including amyloid-beta deposition and cognitive deficits.

Simplified

Funding

Competing interests

3 of 12
authors report competing interests
9 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free